To keep your teams high-performing and achieve better business results, leaders need to understand the hidden costs of DX and ...
IDEXX Laboratories' oncology panel and share buybacks boost outlook. Read why IDXX stock is upgraded to buy with growth ...
Grifols announced on Thursday that it has signed a strategic agreement with Swiss laboratory automation firm Inpeco to provide automated instrumentation, robotics, and software to transfusion medicine ...
The precision cancer business of PHC Holdings anticipates an increase in cancer cases and is expanding its digital pathology and immunohistochemistry instrument lineup.
Dynex Capital, Inc. (NYSE:DX – Get Free Report) has earned a consensus rating of “Moderate Buy” from the five analysts that ...
BPDCN is an aggressive hematologic malignancy with a historically poor prognosis VisualDx is a clinical decision support system used by more than 2,300 hospitals, clinics, and medical schools around ...
14h
Medical Device Network on MSNProscia scoops $50m for AI-driven pathology advancementA US-based pathology software provider has completed a $50m fund raise to advance its artificial intelligence (AI)-driven ...
A good vacuum cleaner saves time and effort by efficiently removing dust, dirt, and allergens from floors, carpets, and ...
StockNews.com initiated coverage on shares of Accelerate Diagnostics (NASDAQ:AXDX – Free Report) in a report released on Monday morning. The firm issued a hold rating on the medical research company’s ...
Twenty-five years later, the bar still boasts late night DJs, chic Scandinavian design, and a happy hour that is nothing shy ...
5h
Digital Camera World on MSNViltrox AF 25mm f/1.7 Air review: another breath of fresh air for APS-C format camerasThe Viltrox AF 25mm f/1.7 Air adds to a growing range of compact, lightweight and supremely affordable ‘Air’ prime lenses ...
No significant news for DX in the past two years. Key Stock Data P/E Ratio (TTM) The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results